Table 2 Association between TSH and parameters of spirometry and cardiopulmonary exercise testing
Model 1 | Model 2 | Model 3 | ||
|---|---|---|---|---|
TSH full range | TSH < 0.3# | TSH > =3# | TSH in the reference range | |
β (95%-CI) | β (95%-CI) | β (95%-CI) | β (95%-CI) | |
FEV 1 ; l | -0.01 (-0.04; 0.01) | 0.06 (-0.06; 0.17) | -0.06 (-0.14; 0.02) | 0.01 (-0.03; 0.04) |
FVC; l | -0.003 (-0.034; 0.028) | 0.03 (-0.10; 0.17) | -0.08 (-0.21; 0.04) | 0.02 (-0.03; 0.06) |
FEV 1 /FVC; % | -0.35* (-0.65; -0.06) | -0.06 (-1.23; 1.12) | -0.78 (-2.02; 0.47) | -0.48* (-0.91; -0.04) |
peakVO 2 ; ml/min | 1.2 (-18.1; 20.4) | 19.2 (-46.4; 84.8) | 3.0 (-98.5; 104.5) | 12.9 (-15.4; 41.3) |
VO 2 @AT; ml/min | -4.7 (-14.8; 5.5) | 14.0 (-19.3; 47.4) | -9.3 (-52.0; 33.5) | -4.2 (-18.2; 9.9) |
O 2 HR; ml/beat | -0.11* (-0.22; -0.01) | 0.33 (-0.14; 0.81) | -0.31 (-0.88; 0.26) | -0.08 (-0.25; 0.08) |
V E vs. VCO 2 slope | 0.11 (-0.06; 0.29) | -0.44 (-1.08; 0.19) | 0.05 (-0.69; 0.79) | 0.21 (-0.05; 0.46) |
Maximum power; watt | 1.3 (-0.1; 2.7) | 0.1 (-5.7; 6.0) | -0.4 (-11.1; 10.3) | 1.9 (-0.1; 3.9) |
Exercise duration; minutes | 0.02 (-0.08; 0.12) | 0.02 (-0.33; 0.37) | -0.16 (-0.62; 0.29) | 0.07 (-0.07; 0.20) |